Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal Cancer

Clinical trial NCT07500298 · RECRUITING

Trial details

NCT number: NCT07500298
Sponsor: M.D. Anderson Cancer Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Phase 1 SAR445877 FOlfox6 Bevacizimab First Line Treatment Metastatic Colorectal Cancer (CRC)Microsatellite Stable

Start date: 2026-05-20
Primary completion: 2030-12-27
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.